| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,584 |
15,549 |
$616K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,723 |
9,394 |
$542K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,852 |
5,717 |
$242K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,405 |
6,897 |
$223K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,264 |
3,199 |
$213K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,644 |
2,484 |
$148K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,273 |
3,052 |
$141K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,677 |
1,570 |
$130K |
| 90461 |
|
2,779 |
2,709 |
$121K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,687 |
1,638 |
$106K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,787 |
5,152 |
$75K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,307 |
2,126 |
$66K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,938 |
1,719 |
$62K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
899 |
843 |
$50K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,940 |
1,600 |
$47K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,957 |
4,645 |
$31K |
| 83655 |
|
2,511 |
2,430 |
$25K |
| 92587 |
|
775 |
752 |
$23K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
271 |
265 |
$20K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
299 |
279 |
$7K |
| 36416 |
|
4,824 |
4,445 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
397 |
325 |
$5K |
| 99177 |
|
894 |
870 |
$2K |
| 90837 |
Psychotherapy, 53 minutes with patient |
27 |
15 |
$2K |
| 87807 |
|
121 |
119 |
$1K |
| 90670 |
|
1,036 |
1,012 |
$927.46 |
| 87486 |
|
64 |
56 |
$844.95 |
| 87581 |
|
64 |
56 |
$844.95 |
| 90698 |
|
999 |
970 |
$557.99 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
62 |
54 |
$489.85 |
| 96127 |
|
106 |
104 |
$271.39 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
41 |
27 |
$266.13 |
| 90680 |
|
536 |
522 |
$210.57 |
| 86308 |
|
22 |
22 |
$111.64 |
| 90686 |
|
1,047 |
1,036 |
$85.29 |
| 94760 |
|
47 |
39 |
$64.03 |
| 81003 |
|
218 |
198 |
$38.36 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
237 |
214 |
$27.53 |
| 90677 |
|
224 |
222 |
$25.08 |
| 90744 |
|
119 |
115 |
$24.22 |
| A4628 |
Oral and/or oropharyngeal suction catheter, each |
38 |
30 |
$21.48 |
| A7002 |
Tubing, used with suction pump, each |
38 |
30 |
$18.66 |
| 36415 |
Collection of venous blood by venipuncture |
29 |
28 |
$11.64 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
44 |
42 |
$1.73 |
| 90656 |
|
64 |
62 |
$0.45 |
| 91307 |
|
21 |
20 |
$0.03 |
| 90651 |
|
14 |
14 |
$0.01 |
| 90619 |
|
12 |
12 |
$0.00 |
| 90697 |
|
14 |
14 |
$0.00 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
38 |
30 |
$0.00 |
| 90633 |
|
93 |
91 |
$0.00 |